NCT02465398

Brief Summary

The purpose of this study is to obtain outcomes data on the Anatomical Shoulder Fracture System by analysis of standard scoring systems and radiographs. Outcome data will be collected using the following standard scoring systems: \- Constant and Murley Score

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2007

Longer than P75 for not_applicable

Geographic Reach
3 countries

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 5, 2007

Completed
7.9 years until next milestone

First Submitted

Initial submission to the registry

June 4, 2015

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 8, 2015

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 29, 2017

Completed
7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 11, 2024

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

June 12, 2025

Completed
Last Updated

June 12, 2025

Status Verified

February 1, 2025

Enrollment Period

9.7 years

First QC Date

June 4, 2015

Results QC Date

February 24, 2025

Last Update Submit

May 27, 2025

Conditions

Keywords

Fracture shoulder arthroplastyThree or four part fractureHemiarthroplastyMulti-centerEuropeNon-controlledAnatomical reconstructionProximal

Outcome Measures

Primary Outcomes (1)

  • Functional Performance

    Constant \& Murley Score. This evaluates clinical parameters such as range of motion, power, level of pain and functional ability. The score ranges from 0 - 100 with a higher score representing a better outcome.

    5 years

Study Arms (1)

Fracture device

OTHER

Patient were treated with an Anatomical Shoulder Fracture device.

Procedure: Fracture Shoulder Arthroplasty

Interventions

Implantation of the Anatomical Shoulder Fracture System

Fracture device

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age - 18 years minimum.
  • Sex - male and female.
  • General Health - the patient should be able to undergo surgery and participate in a follow-up program based upon physical examination and medical history.
  • Informed Consent - patient or patient's legal representative has signed a 'Patient Informed Consent form'.
  • Indications - Diagnosis of trauma in the affected joint with the indication for shoulder hemiarthroplasty.

You may not qualify if:

  • Patient is skeletally immature.
  • Patient is pregnant.
  • Patient is unwilling or unable to cooperate in a follow-up program.
  • Patient is planned for a bilateral shoulder replacement.
  • Patient shows one or more of the following medical conditions:
  • Pathological Fracture
  • Active Infection
  • Patient requires one or more of the following medical interventions:
  • Revision surgery (non-union)
  • Inverse fracture prosthesis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Klinikum Augsburg

Augsburg, 86156, Germany

Location

Uniklinik Balgrist

Zurich, 8008, Switzerland

Location

The Pennine Acute Hospital NHS Trust

Manchester, M8 5RB, United Kingdom

Location

MeSH Terms

Conditions

Fractures, Bone

Condition Hierarchy (Ancestors)

Wounds and Injuries

Results Point of Contact

Title
Elliott Goff
Organization
Zimmer Biomet

Study Officials

  • Elliott Goff, PhD

    Zimmer Biomet, Jr. Clinical Project Lead

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
GT60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 4, 2015

First Posted

June 8, 2015

Study Start

July 5, 2007

Primary Completion

March 29, 2017

Study Completion

March 11, 2024

Last Updated

June 12, 2025

Results First Posted

June 12, 2025

Record last verified: 2025-02

Locations